ConductScience.org, home

Paper17524139

Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma.

Chang CS and 4 others. BMC Cancer, 2007. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma. Papers, record 17524139. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17524139

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma.
PubMed
Journal
BMC Cancer
PubMed
Year
2007
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chang CSCheng-Shyong
2Chang JHJulia H
3Hsu NCNicholas C
4Lin HYHsuan-Yu
5Chung CYChih-Yuan

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B7-1 AntigenMajor topic
B7-2 AntigenMajor topic
Biomarkers, TumorMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Nasopharyngeal NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Survival Rate

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112586799Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.J Clin Oncol2003https://conductscience.org/library/papers/12586799PubMed
212610501Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.Br J Cancer2003https://conductscience.org/library/papers/12610501PubMed
312784235Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.Head Neck2003https://conductscience.org/library/papers/12784235PubMed
415190138Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.N Engl J Med2004https://conductscience.org/library/papers/15190138PubMed
52794510B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.J Immunol1989https://conductscience.org/library/papers/2794510PubMed
61313950CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.Nature1992https://conductscience.org/library/papers/1313950PubMed
717201120Endogenous expression of CD80 co-stimulatory molecule facilitates in vivo tumor regression of oral squamous carcinoma.Anticancer Res2006https://conductscience.org/library/papers/17201120PubMed
87694363Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.Science1993https://conductscience.org/library/papers/7694363PubMed
97573360
Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.
Am J Pathol1995https://conductscience.org/library/papers/7573360PubMed
108717514CD28/B7 system of T cell costimulation.Annu Rev Immunol1996https://conductscience.org/library/papers/8717514PubMed
119552031Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.J Clin Oncol1998https://conductscience.org/library/papers/9552031PubMed
1210403546Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: indicative of an activated status.Cancer Lett1999https://conductscience.org/library/papers/10403546PubMed
137694153B70 antigen is a second ligand for CTLA-4 and CD28.Nature1993https://conductscience.org/library/papers/7694153PubMed

Download CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42794643CD80 as an Important Immune Mediator and Therapeutic Target in Atherosclerosis.Int J Mol Sci2026https://conductscience.org/library/papers/42794643PubMed
37614091Clinicopathologic Evaluation of CD80, CD86, and PD-L1 Expressions with Immunohistochemical Methods in Malignant Melanoma Patients.Turk Patoloji Derg2024https://conductscience.org/library/papers/37614091PubMed
36922519Comprehensive characterization of B7 family members in NSCLC and identification of its regulatory network.Sci Rep2023https://conductscience.org/library/papers/36922519PubMed
36558399Thymoquinone Effect on Monocyte-Derived Macrophages, Cell-Surface Molecule Expression, and Phagocytosis.Nutrients2022https://conductscience.org/library/papers/36558399PubMed
36428666Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy.Cancers (Basel)2022https://conductscience.org/library/papers/36428666PubMed
34803925Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34803925PubMed
33092083A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes.Cancers (Basel)2020https://conductscience.org/library/papers/33092083PubMed
32602047The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites.Curr Oncol Rep2020https://conductscience.org/library/papers/32602047PubMed
30719121Dendritic cell subpopulations in nasopharyngeal cancer.Oncol Lett2019https://conductscience.org/library/papers/30719121PubMed
26453114IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.Tumour Biol2016https://conductscience.org/library/papers/26453114PubMed
21577326Paucilymphoid non-keratinizing nasopharyngeal carcinoma with prominent stromal desmoplasia--an unusual case reported with brief comments on uncommon histological variants.Int J Clin Exp Pathol2011https://conductscience.org/library/papers/21577326PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17524139

GET https://conductscience.org/api/papers/v1/17524139/authors